LIFE SCIENCE GROUP LIMITED


LIFE SCIENCE GROUP LIMITED

Company Registration Number:
06606016 (England and Wales)

Unaudited abridged accounts for the year ended 31 May 2019

Period of accounts

Start date: 01 June 2018

End date: 31 May 2019

LIFE SCIENCE GROUP LIMITED

Contents of the Financial Statements

for the Period Ended 31 May 2019

Balance sheet
Notes

LIFE SCIENCE GROUP LIMITED

Balance sheet

As at 31 May 2019


Notes

2019

2018


£

£
Fixed assets
Tangible assets: 3 27,057 22,245
Total fixed assets: 27,057 22,245
Current assets
Stocks: 451,731 554,675
Debtors:   454,543 194,952
Cash at bank and in hand: 35,937 161,459
Total current assets: 942,211 911,086
Creditors: amounts falling due within one year:   (1,087,472) (1,152,197)
Net current assets (liabilities): (145,261) (241,111)
Total assets less current liabilities: (118,204) (218,866)
Total net assets (liabilities): (118,204) (218,866)
Capital and reserves
Called up share capital: 1 1
Profit and loss account: (118,205) (218,867)
Shareholders funds: (118,204) (218,866)

The notes form part of these financial statements

LIFE SCIENCE GROUP LIMITED

Balance sheet statements

For the year ending 31 May 2019 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 26 February 2020
and signed on behalf of the board by:

Name: J Murray
Status: Director

The notes form part of these financial statements

LIFE SCIENCE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2019

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Tangible fixed assets and depreciation policy

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:Short leasehold property - 20% straight line basisFF & equipment - 25% reducing balance basisIf there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Intangible fixed assets and amortisation policy

Research and developmentResearch expenditure is written off in the year in which it is incurred.Development expenditure incurred is capitalised as an intangible asset only when all of the following criteria are met:- It is technically feasible to complete the intangible asset so that it will be available for use or sale;- There is the intention to complete the intangible asset and use or sell it;- There is the ability to use or sell the intangible asset;- The use or sale of the intangible asset will generate probable future economic benefits;- There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and- The expenditure attributable to the intangible asset during its development can be measured reliablyExpenditure that does not meet the above criteria is expensed as incurred.

Other accounting policies

TaxationThe taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.Tangible assetsTangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.ImpairmentA review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. StocksStocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.ProvisionsProvisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.Financial instrumentsA financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

LIFE SCIENCE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2019

2. Employees

2019 2018
Average number of employees during the period 11 11

LIFE SCIENCE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2019

3. Tangible Assets

Total
Cost £
At 01 June 2018 179,785
Additions 23,402
At 31 May 2019 203,187
Depreciation
At 01 June 2018 157,540
Charge for year 18,590
At 31 May 2019 176,130
Net book value
At 31 May 2019 27,057
At 31 May 2018 22,245

LIFE SCIENCE GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2019

4. Financial commitments

The company has created a Debenture dated 23 August 2016 in favour of HSBC Bank plc being a fixed and floating charge over all its assets, to secure a working capital and overdraft facility.